Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat
Saturday, September 26, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
Tirzepatide, sold as Mounjaro and Zepbound, activated calorie-burning brown fat in obese mice, revealing a potential metabolic effect beyond appetite suppression. If confirmed in humans, the finding could help explain the drug’s powerful benefits and inspire more comprehensive treatments for obesity and diabetes. (via Science Daily)
Read the Full StoryThis article will expire in 29 days.
In the News...
View All Recent News
- A major risk of breast cancer screening may have been overestimated for decades
- Don’t toss cannabis leaves: They may contain rare compounds with medical potential
- That fresh cleaning smell could be filling your home with nanoparticles
- REM sleep paradox: Dreaming may drain the brain’s energy even as fuel supply rises
- Zepbound and Mounjaro may turn on the body’s calorie-burning brown fat
- This “rare” autism-linked genetic disorder may be far more common than scientists thought
- CRISPR could help doctors attack blood cancer without destroying healthy cells
- Scientists discover an “impossible” cellular survival pathway that could help fight cancer
- Scientists gave worms magnetic bacteria. They lived 43% longer
- Aging muscles may be losing strength for a reason scientists missed
- When what you see doesn’t make sense, your brain does something remarkable
- Scientists thought they knew how this 70-year-old leukemia drug worked
- Rare pregnancy infections may triple the risk of autism
- Breakthrough drug reverses skin aging and dramatically speeds healing
- GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
- More REM sleep linked to lower risk of 83 diseases
- This new drug could break cancer’s resistance to treatment
- Coffee doesn’t have to keep you awake to disrupt your sleep
- This emerging treatment could help people avoid knee replacement surgery
- Brain scans reveal a possible cause of long COVID fatigue and brain fog